Skip to main content
Article thumbnail
Location of Repository

Niobium uptake and release by bacterial ferric ion binding protein

By Yanbo Shi, Ian Harvey, Dominic Campopiano and P. J. Sadler


Ferric ion binding proteins (Fbps) transport FeIII across the periplasm and are vital for the virulence of many Gram negative\ud bacteria. Iron(III) is tightly bound in a hinged binding cleft with octahedral coordination geometry involving binding to protein\ud side chains (including tyrosinate residues) together with a synergistic anion such as phosphate. Niobium compounds are of\ud interest for their potential biological activity, which has been little explored. We have studied the binding of cyclopentadienyl\ud and nitrilotriacetato NbV complexes to the Fbp from Neisseria gonorrhoeae by UV-vis spectroscopy, chromatography, ICP-OES,\ud mass spectrometry, and Nb K-edge X-ray absorption spectroscopy. These data suggest that NbV binds strongly to Fbp and that a\ud dinuclear NbV centre can be readily accommodated in the interdomain binding cleft. The possibility of designing niobium-based\ud antibiotics which block iron uptake by pathogenic bacteria is discussed

Topics: QR
Publisher: Hindawi Publishing Corporation
Year: 2010
OAI identifier:

Suggested articles


  1. (2003). A novel protein-mineral interface,” doi
  2. (1986). Antitumor metallocenes: new developments and toxicologic features,”
  3. (2000). Antitumour metallocenes: structure-activity studies and interactions with biomolecules,” doi
  4. (2004). Assembly of an oxozirconium(IV) cluster in a protein cleft,” doi
  5. (1994). Coordination of iron by the ferric iron-binding protein of pathogenic doi
  6. Disordering of the [NbOF5] 2− complex anions in bis(glycinium) pentafluoridooxidoniobate(V) doi
  7. (1969). Effects of electron-electron interaction on oneelectron properties of atoms and solids,”
  8. (1998). G´ o m e z ,M .T .C r i a d o ,a n dC .M .F e r r e i r´ os, “Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants,” doi
  9. giant cell formation after treatment of Ehrlich ascites tumor with metallocene dichlorides,” doi
  10. (2000). Heterometallic lithium niobium complexes: synthesis and molecular structures of doi
  11. (1996). i n t o r ,L .F e r r´ o n doi
  12. (2004). Iron and microbial infection,” doi
  13. (2007). Iron metabolism and infection,” doi
  14. (2003). Kinetics and mechanism of iron release from the bacterial ferric binding protein nFbp: exogenous anion influence and comparison with mammalian transferrin,” doi
  15. (2000). Kr¨ o g e r ,U .R .K l e e b e r g ,K .M r o s s ,L .E d l e r ,G .S a ß ,a n dD .
  16. (2008). Metal trafficking via siderophores in Gramnegative bacteria: specificities and characteristics of the pyoverdine pathway,” doi
  17. (1979). Molybdocen-dichlorid als antitumor-agens,”
  18. (1987). Non-platinum-group metal antitumor agents: history, current status, and perspectives,” doi
  19. (2008). o m d e n ,C .R e d s h a w ,J .A .W r i g h t ,D .L .H u g h e s ,a n d doi
  20. (1999). o s ,M .T .C r i a d o ,a n dJ .A .G ´ omez, “The neisserial 37kDa ferric binding protein
  21. (1999). opf-Maier, “Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma,”
  22. (1983). opf-Maier, “Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment,” doi
  23. (1996). Organometallic anticancer agents. 2. Aqueous chemistry and interaction of niobocene dichloride with nucleic acid constituentsandaminoacids,”JournalofMedicinalChemistry, doi
  24. (1992). otke, “Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states,” doi
  25. (2003). Oxo-iron clusters in a bacterial iron-trafficking protein: new roles for a conserved motif,” doi
  26. (1990). Scattering-matrix formulation of curved-wave multiple-scattering theory: application to X-rayabsorption fine structure,” doi
  27. (2006). Short oxo-titanium(IV) bond in bacterial transferrin: a protein target for metalloantibiotics,” doi
  28. (1995). Studies of metalloproteins using EXAFS and XPD,P h . D . thesis,
  29. (2003). Synergistic anion and metal binding to the ferric ion-binding protein from Neisseria gonorrhoeae,” doi
  30. (1986). T h e n ,H .A p p e l ,J .D u doi
  31. (2008). The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent,” doi
  32. (1991). Theoretical X-ray absorption fine structure standards,” doi
  33. (2000). Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride,” doi
  34. (1979). Titanocene dichloride—the first metallocene with cancerostatic activity,” doi
  35. (1999). Transferrin as a metal ion mediator,” doi
  36. (1980). Tumor inhibition by metallocenes: antitumor activity of niobocene and tungstocene dichlorides,” doi
  37. (1989). Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract,” doi
  38. (1987). Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas,” doi
  39. (1987). Tumor inhibition by titanocene complexes.
  40. (2002). Unusualfeaturesforzirconium(IV)bindingtohumanserum transferrin,”
  41. (2005). V a nB a e l ,I .A r c o n ,K .V a nW e r d e ,D .N e l i s

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.